01 1AX Pharmaceutical Corp
02 1Sekisui Medical Co., Ltd.
01 2Clemastine Fumarate
01 1Canada
02 1Japan
NDC Package Code : 73377-061
Start Marketing Date : 2020-07-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 55152-001
Start Marketing Date : 2020-06-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Clemastine (fumarate) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clemastine (fumarate), including repackagers and relabelers. The FDA regulates Clemastine (fumarate) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clemastine (fumarate) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clemastine (fumarate) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Clemastine (fumarate) supplier is an individual or a company that provides Clemastine (fumarate) active pharmaceutical ingredient (API) or Clemastine (fumarate) finished formulations upon request. The Clemastine (fumarate) suppliers may include Clemastine (fumarate) API manufacturers, exporters, distributors and traders.
click here to find a list of Clemastine (fumarate) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Clemastine (fumarate) as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Clemastine (fumarate) API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Clemastine (fumarate) as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Clemastine (fumarate) and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Clemastine (fumarate) NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Clemastine (fumarate) suppliers with NDC on PharmaCompass.
We have 2 companies offering Clemastine (fumarate)
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
